Porvair plc (LON:PRV – Get Free Report) insider Hooman Caman Javvi acquired 1,100 shares of the business’s stock in a transaction that occurred on Monday, February 23rd. The stock was purchased at an average price of GBX 819 per share, for a total transaction of £9,009.
Hooman Caman Javvi also recently made the following trade(s):
- On Friday, February 20th, Hooman Caman Javvi purchased 5,934 shares of Porvair stock. The stock was purchased at an average price of GBX 836 per share, for a total transaction of £49,608.24.
- On Monday, February 9th, Hooman Caman Javvi purchased 5,701 shares of Porvair stock. The shares were acquired at an average cost of GBX 870 per share, for a total transaction of £49,598.70.
Porvair Stock Performance
Shares of LON PRV opened at GBX 818 on Thursday. Porvair plc has a 12-month low of GBX 624.70 and a 12-month high of GBX 920. The company has a current ratio of 1.83, a quick ratio of 1.22 and a debt-to-equity ratio of 19.67. The company has a market cap of £377.39 million, a PE ratio of 22.29 and a beta of 0.76. The stock has a 50 day simple moving average of GBX 849.54 and a 200-day simple moving average of GBX 788.13.
Analyst Ratings Changes
Separately, Shore Capital Group restated a “hold” rating on shares of Porvair in a research report on Monday, February 9th. One investment analyst has rated the stock with a Hold rating, According to data from MarketBeat, Porvair presently has an average rating of “Hold”.
Read Our Latest Stock Report on PRV
Porvair Company Profile
Porvair plc engages in the filtration, laboratory, and environmental technology business. It operates through three segments: Aerospace & Industrial, Laboratory, and Metal Melt Quality. The Aerospace & Industrial segment designs and manufactures a range of specialist filtration equipment for aerospace, energy, and industrial applications. The Laboratory segment is involved in the design and manufacture of instruments and consumables for use in environmental and bioscience laboratories with a focus on water analysis instruments, diagnostics, and sample preparation equipment.
Recommended Stories
- Five stocks we like better than Porvair
- REVEALED: Something Big Happening Behind White House Doors
- This makes me furious
- Elon Musk’s New 1,000X Opportunity
- The Fed Just Got Kneecapped — Here’s What Happens Next
- ALERT: Drop these 5 stocks before the market opens tomorrow!
Receive News & Ratings for Porvair Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Porvair and related companies with MarketBeat.com's FREE daily email newsletter.
